M.S. AAI Capstone Chronicles 2024

We envision developing a unified pipeline to synchronize insights across all datasets, creating seamless interactions between dietary, glucose, and long-term control components. Additionally, incorporating domain-specific constraints such as safety thresholds for insulin dosing, would ensure reliable and clinically acceptable outputs in the real world. The proposed system has the potential to revolutionize diabetes management by providing a personalized, data-driven solution. Practical applications span multiple areas, empowering patients with actionable insights into glucose trends, dietary impacts, and long-term glycemic control. This would also assist healthcare providers in designing tailored treatment plans and potentially reducing healthcare costs by improving glycemic control and minimizing adverse events. To transition from research to real-world deployment, we've identified several critical implementation steps. Regulatory compliance will require adherence to healthcare standards like HIPAA and GDPR for data privacy, alongside FDA approval validation for clinical use. The system deployment phase will focus on developing user-friendly interfaces for both patients and clinicians, while optimizing computational requirements for real-time predictions on edge devices such as smartphones and insulin pumps. The final phase will involve comprehensive pilot studies and user feedback collection to evaluate the system's real-world performance and refine its features based on end-user experiences. By addressing these steps, the system can transition from an academic prototype to a scalable, impactful solution, improving quality of life for individuals with diabetes worldwide. This

18

252